Project description
Wearable bio-electronic device for the treatment of peripheral arterial disease
Life-threatening peripheral arterial disease (PAD) affects 200 million people worldwide and is the third cause of cardiovascular morbidity. This condition is associated with the arteries narrowing, reduced blood flow, chronic pain and critical limb ischaemia. PAD’s progression leads to gangrene, amputations and even death. Austrian company AURIMOD has developed a wearable device with the potential to improve all symptoms of PAD. The device is applied to the patient’s ear and sends specific electrical stimulation to the auricular branches of the vagus nerve. This non-invasive treatment might prevent PAD complications, including chronic wounds and amputations. The EU-funded AuriMod project will focus on product development, a business model for it and the potential supply chain.
Objective
Peripheral Arterial Disease (PAD) is a life-threatening disease affecting 200 M people in the world (40.5 M only in EU) and represents the third cause of world cardiovascular morbidity. PAD is a chronic condition generated by the narrowing of arteries, which reduces the normal blood flow and triggers a wide range of manifestations mostly in the lower limbs, from chronic pain to critical limb ischemia. PAD’s progression can lead to chronic wounds, gangrene, amputation, and in most severe cases, death. There is no current solution able to target the broad range of symptoms and complications related to PAD. AuriMod is a wearable device for non-invasive auricular stimulation of the vagus nerve that is capable of treating all symptoms of PAD, avoiding conventional drugs’ side effects and preventing complications including chronic wounds and consequent amputations. Applied to the patient’s ear, AuriMod sends specific electrical stimulation to the auricular branches of the vagus nerve, delivering a patient-tailored therapy that will improve the quality of life of PAD patients. This Phase 1 project will mainly focus on planning further product development, verifying the current supply chain, evaluating the business model and commercialisation plan. The overall innovation project will enable to optimise AuriMod device, conduct clinical trials to validate safety and effectiveness of AuriMod-based therapy and acquire all certifications required for AuriMod’s commercialisation.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine immunology autoimmune diseases
- medical and health sciences clinical medicine peripheral vascular disease
- engineering and technology medical engineering wearable medical technology
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-SMEInst-2016-2017
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
1030 WIEN
Austria
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.